Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents

European Journal of Medicinal Chemistry

Volumn 44, Issue 5, 2009, Pages 2294-2299

  Ansari, K F ^a   Lal, C ^a  

^a HARCOURT BUTLER TECHNOLOGICAL INSTITUTE   (India)

Author keywords

2 Benzimidazoles; Antibacterial activity; Antifungal activity; Azetidin 2 ones; Thiadiazole

Indexed keywords

2 [(2 METHYL 1H BENZIMIDAZOL 1 YL)ACETYL]HYDRAZINECARBOTHIOAMIDE; 2 [[[5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]IMINO]METHYL]PHENOL; 3 [[[5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]IMINO]METHYL]PHENOL; 3 CHLORO 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL) METHYL] 1,3,4 THIADIAZOL 2 YL] 4 (2 METHYLPHENYL)AZETIDIN 2 ONE; 3 CHLORO 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL] 4 (3 METHYLPHENYL)AZETIDIN 2 ONE; 3 CHLORO 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL] 4 (4 METHYLPHENYL)AZETIDIN 2 ONE; 3 CHLORO 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL] 4 PHENYLAZETIDIN 2 ONE; 3 CHLORO 4 (2 CHLOROPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (2 HYDROXYPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (2 METHOXYPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (3 HYDROXYPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (4 CHLOROPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (4 HYDROXYPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (4 METHOXYPHENYL) 1 [5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 4 [[[5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]IMINO]METHYL]PHENOL; 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] N (PHENYL METHYLIDENE) 1,3,4 THIADIAZOL 2 AMINE; 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] N [(2 METHYLPHENYL)METHYLIDENE] 1,3,4 THIADIAZOL 2 AMINE; 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] N [(3 METHYLPHENYL)METHYLIDENE] 1,3,4 THIADIAZOL 2 AMINE; AMPHOTERICIN B; AMPICILLIN; BENZIMIDAZOLE DERIVATIVE; ETHYL (2 METHYL 1H BENZIMIDAZOL 1 YL)ACETATE; N [(2 CHLOROPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N [(2 METHOXYPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N [(4 AMINOPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N [(4 BROMOPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N [(4 CHLOROPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N [(4 METHOXYPHENYL)METHYLIDENE] 5 [(2 METHYL 1H BENZIMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CATALYST; CYCLOADDITION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERIZATION; SPECTROSCOPY;

ALDEHYDES; AMINES; ANTI-INFECTIVE AGENTS; AZETIDINES; CATALYSIS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE;

EID: 62549104303     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.01.022     Document Type: Article

References (25)

1. Bishop B.C., Chelton E.T.J., and Jones A.S. Biochem. Pharmacol. 13 (1964) 751-754
2. Habib N.S., Soliman R., Ashoura F.A., and El-Taiebi M. Pharmazie 55 (1997) 746-749
3. Tuncbilek M., Goker H., Ertan R., Eryigit R., Kendi E., and Altanlar E. Arch. Pharm. 330 (1997) 372-376
4. Goker H., Kus C., Boykin D.W., Yildiz S., and Altanlar N. Arch. Pharm. 334 (2001) 148-152
5. Goker H., Kus C., Boykin D.W., Yildiz S., and Altanlar N. Bioorg. Med. Chem. 10 (2002) 2589-2596
6. Pawar N.S., Dalal D.S., Shimpi S.R., and Mahulikan P.P. Eur. J. Pharm. Sci. 21 (2004) 115-118
7. Mohammad B.G., Hussein M.A., Abdel-Alim A.A., and Hashem M. Arch. Pharm. Res. 29 (2006) 26-33
8. Vaidya S.D., Kumar B.V.S., Kumar R.V., Bhise U.N., and Mashelkar U.C. J. Heterocycl. Chem. 44 (2007) 685-691
9. Preston P.N. Chem. Rev. 74 (1974) 279-314
10. Dubey R., Abuzar S., Sharma S., Chatterjee R.K., and Katiyar J.C. J. Med. Chem. 28 (1985) 1748-1750
11. Lazer E.S., Matteo M.R., and Possanza G.J. J. Med. Chem. 30 (1987) 726-729
12. Nakano H., Inoue T., Kawasaki N., Miyataka H., Matsumoto H., Taguchi T., Inagaki N., Nagai H., and Satoh T. Chem. Pharm. Bull. 47 (1999) 1573-1578
13. El-Masry A.H., Fahmy H.H., and Abdelwahed S.H.A. Molecules 5 (2000) 1429-1438
14. Castelli M., Malagoli M., Lupo L., Riccomi T.R., Casolari C., Cermelli C., Zanca A., and Baggio G. Pharm. Toxicol. 88 (2001) 67-74
15. Joshi D.G., Oza H.B., and Parekh H.H. Ind. J. Heterocycl. Chem. 11 (2001) 145-148
16. Kazimierczuk Z., Upcroft J.A., Upcroft P., Gorska A., Starosciak B., and Laudy A. Acta Biochim. Polon. 49 (2002) 185-195
17. Goudgaon M.M., Dhondika V., and Vijayalaxmi A. Ind. J. Heterocycl. Chem. 13 (2004) 271-272
18. Goker H., Ozden S., Yildiz S., and Boykin D.W. Eur. J. Med. Chem. 40 (2005) 1062-1069
19. Kumar R.V., Gopal K.R., and Sheshu Kumar K.V.S.R. J. Heterocycl. Chem. 42 (2005) 1405-1408
20. Starcevic K., Kralj M., Ester K., Sabol I., Grce M., Pavelic K., and Karminski-Zamola G. Bioorg. Med. Chem. 15 (2007) 4419-4426
21. Hogale M.B., Uthale A.C., and Nikam B.P. Ind. J. Chem. 30B (1991) 717-720
22. Srivastava S.K., Srivastava S., and Srivastava S.D. Ind. J. Chem. 41B (2002) 2357-2363
23. Desai K.G., and Desai K.R. Bioorg. Med. Chem. 14 (2006) 8271-8279
24. In: Furniss B.S., Hannaford A.J., Smith P.W.G., and Tatchell A.R. (Eds). Vogel's Text Book of Practical Organic Chemistry (1998), ELBS Longman, England
25. Barry A.L. The Antimicrobial Susceptibility Tests, Principle and Practices (1976), Illus Lea and Fehiger, Philadelphia